Acrivon ACRV Full Analysis Acrivon Therapeutics Inc posts 93 EPS miss with no revenue Simpson SSD Stock Strengthening Gains 20260418 JRVR James shares fall 35 after Q1 EPS misses estimates by 57 raising concerns about growth trajectory